Weber, M
Mit unheilbar Kranken sprechen – Kommunikation in der PalliativmedizinKrebsmedizin. Bd. 18. 2009 S. 27-30
Haasler, I; Korn, S; Buhl, R et al.
Moderne AsthmatherapieMMW. Bd. 151. 2009 S. 38-42
Buchmann, I; Meyer, RG; Mier, W et al.
Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: closing the gap between benefit and toxicity?Eur J Nucl Med Mol Imaging. Bd. 36. H. 3. 2009 S. 484-98
Zimmermann, O; Bienek-Ziolkowski, M; Wolf, B et al.
Myocardial inflammation and non-ischaemic heart failure: is there a role for C-reactive protein?Basic Res Cardiol. Bd. 104. H. 5. 2009 S. 591-9
Korn, S; Thielen, A; Seyfried, S et al.
Omalizumab in patients with severe persistent allergic asthma in a real-life setting in GermanyRespir Med. Bd. 103. H. 11. 2009 S. 1725-31
Janetzki, S; Price, L; Britten, CM et al.
Performance of serum-supplemented and serum-free media in IFN-gamma Elispot assays for human T cellsCancer Immunol Immunother. 2009 S. Nov 6 Epub
Hess, G; Herbrecht, R; Romaguera, J et al.
Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma.J Clin Oncol. Bd. 27. H. 23. 2009 S. 3822-9
Schlitt, A; Blankenberg, S; Bickel, C et al.
PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene studyJ Lipid Res. Bd. 50. H. 4. 2009 S. 723-9
Wojiski, S; Guibal, FC; Kindler, T et al.
PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors.Leukemia. Bd. 23. H. 8. 2009 S. 1462-71
Musyanovych, A; Landfester, K; Mailänder, V
Polymeric Nanoparticles as Carrier Systems: How does the material and surface charge affect cellular uptake?B.H. Mitchem, C.I. Sharnham (Hrsg). Clinical Chemistry Research. NovaScience Publisher 2009